BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4382373)

  • 1. Central hypotensive effect of alpha-methyldopa.
    Henning M; Van Zwieten PA
    J Pharm Pharmacol; 1967 Jun; 19(6):403-5. PubMed ID: 4382373
    [No Abstract]   [Full Text] [Related]  

  • 2. Central hypotensive effect of alpha-methyldopa.
    Henning M; van Zwieten PA
    J Pharm Pharmacol; 1968 Jun; 20(6):409-17. PubMed ID: 4386523
    [No Abstract]   [Full Text] [Related]  

  • 3. Central hypotensive effect of alpha-methyldopa.
    Henning M; van Zwieten PA
    Acta Pharmacol Toxicol (Copenh); 1967; 25():Suppl 4:25. PubMed ID: 5630931
    [No Abstract]   [Full Text] [Related]  

  • 4. Blood pressure and noradrenaline levels after treatment with alpha-methyldopa, alpha-methyldopamine and alpha-methyl-m-tyrosine.
    Henning M
    J Pharm Pharmacol; 1967 Nov; 19(11):775-9. PubMed ID: 4383705
    [No Abstract]   [Full Text] [Related]  

  • 5. Interaction of DOPA decarboxylase inhibitors with the effect of alpha-methyldopa on blood pressure and tissue monoamines in rats.
    Henning M
    Acta Pharmacol Toxicol (Copenh); 1969; 27(2):135-48. PubMed ID: 5819569
    [No Abstract]   [Full Text] [Related]  

  • 6. A centrally mediated peripheral hypotensive effect of alpha-methyldopa.
    Ingenito AJ; Barrett JP; Procita L
    J Pharmacol Exp Ther; 1970 Dec; 175(3):593-9. PubMed ID: 5489916
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of alpha-methyldopa, reserpine, guanethidine, and iproniazid on minimum alveolar anesthetic requirement (MAC).
    Miller RD; Way WL; Eger EI
    Anesthesiology; 1968; 29(6):1153-8. PubMed ID: 5726752
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hypotensive drugs and tissue noradrenaline].
    Jori A; Mortari A; Sioli G; Valzelli L
    Boll Soc Ital Biol Sper; 1964 Nov; 40(22):1421-3. PubMed ID: 5876862
    [No Abstract]   [Full Text] [Related]  

  • 9. Further studies on the mechanism of the central hypotensive effect of L-dopa, DL-m-tyrosine and L-alpha-methyldopa.
    Rubenson A
    J Pharm Pharmacol; 1971 Mar; 23(3):228-30. PubMed ID: 4396899
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of different dopa decarboxylase inhibitors on the hypotensive response to alpha-methyldopa in rats.
    Henning M
    Br J Pharmacol; 1968 Sep; 34(1):233P-234P. PubMed ID: 5676035
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence that the hypotensive action of methyldopa is mediated by central actions of methylnoradrenaline.
    Henning M; Rubenson A
    J Pharm Pharmacol; 1971 Jun; 23(6):407-11. PubMed ID: 4397178
    [No Abstract]   [Full Text] [Related]  

  • 12. On the role of alpha-methyldopamine in the antihypertensive effect of alpha-methyldopa.
    Waldmeier P; Hedwal PR; Maître L
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 289(3):303-14. PubMed ID: 169487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liberation of alpha-methyldopamine as a "false" sympathetic transmitter after pretreatment of cats with alpha-methyldopa and disulfiram.
    Thoenen H; Haefely W; Gey KF; Hürlmann A
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 258(2):181-96. PubMed ID: 4385111
    [No Abstract]   [Full Text] [Related]  

  • 14. Importance of central serotonin neurons in the hypotensive action of methyldopa in the rat.
    Choy VJ; Chalmers J
    Clin Exp Pharmacol Physiol; 1984; 11(1):37-44. PubMed ID: 6713735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of omega-amino-acids on blood pressure, catecholamine stores and the pressor response to physostigmine in the rat.
    Hedwall PR; Maître L; Brunner H
    J Pharm Pharmacol; 1968 Oct; 20(10):737-43. PubMed ID: 4386740
    [No Abstract]   [Full Text] [Related]  

  • 16. Central hypotensive action of alpha-methyldopa: an iontophoretic study in the cat.
    Sharma JN; Sandrew BB; Wang SC
    Arch Int Pharmacodyn Ther; 1979 Sep; 241(1):92-9. PubMed ID: 526073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On suppression of ejaculation by Alpha-methyldopa.
    Kimura Y; Tadano T; Urano S; Yonezawa A; Watanabe H; Kisara K
    Andrologia; 1984; 16(2):118-23. PubMed ID: 6742462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The central component of the blood pressure lowering effect of alpha-methyldopa in cats].
    Henning M; van Zwieten PA
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):140-1. PubMed ID: 4239179
    [No Abstract]   [Full Text] [Related]  

  • 19. On the localization of the hypotensive effect of L-dopa.
    Henning M; Rubenson A; Trolin G
    J Pharm Pharmacol; 1972 Jun; 24(6):447-51. PubMed ID: 4403826
    [No Abstract]   [Full Text] [Related]  

  • 20. Further evidence for a central hypotensive action of alpha-methyldopa in both the rat and cat.
    Finch L; Haeusler G
    Br J Pharmacol; 1973 Feb; 47(2):217-28. PubMed ID: 4722038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.